Japan's Takeda to sell some Asia-focused drugs to Celltrion for $278 million

Takeda Pharmaceutical Co Ltd has agreed to sell a portfolio of over-the-counter and prescription drugs marketed in the Asia Pacific region to South Korea's Celltrion Inc for $278 million, it said on Thursday